Road traffic musculoskeletal injuries (RTMIs) constitute a significant public health challenge globally, with substantial morbidity, disability, and socioeconomic impact. Population surveillance enables systematic tracking of RTMIs, providing crucial data to inform preventive strategies, optimize clinical management, and guide health policy. This review synthesizes recent evidence on the burden, mechanisms, risk factors, clinical presentations, diagnostic approaches, therapeutic modalities, emerging advances, and expert guideline recommendations related to RTMIs, emphasizing practical implications for clinicians and healthcare systems.
Musculoskeletal injuries resulting from road traffic accidents represent a major cause of trauma-related morbidity and mortality worldwide. With increasing vehicular density and urbanization, the incidence of RTMIs has risen, placing a considerable strain on healthcare resources. Surveillance of these injuries at a population level is pivotal for understanding epidemiological trends, identifying high-risk groups, and evaluating the effectiveness of interventions. This article provides a comprehensive overview of RTMIs, integrating clinical, epidemiological, and policy perspectives for healthcare professionals.
Globally, the World Health Organization (WHO) estimates that road traffic injuries (RTIs) account for approximately 1.35 million deaths annually, with tens of millions suffering non-fatal injuries, a significant proportion of which are musculoskeletal. Population-based surveillance studies reveal that musculoskeletal trauma, including fractures, dislocations, sprains, and soft tissue injuries, constitutes up to 60% of RTI presentations in emergency departments. The burden is disproportionately higher in low- and middle-income countries (LMICs), often due to rapid urbanization, inadequate road safety measures, and limited trauma care infrastructure. RTMIs frequently result in prolonged disability, reduced quality of life, and substantial economic losses due to healthcare costs and lost productivity.
The pathophysiology of RTMIs is dictated by the transfer of kinetic energy during collisions, falls, or run-overs, leading to tissue deformation and failure. High-velocity impacts commonly result in complex, multi-system injuries with musculoskeletal trauma including long bone fractures, pelvic disruptions, and ligamentous injuries. Secondary injury mechanisms such as ischemia, compartment syndrome, and infection further complicate outcomes. The biomechanical forces involved vary according to the type of collision, position of the victim, use of protective devices, and vehicle speed. Understanding these mechanisms is essential for developing tailored preventive and therapeutic approaches.
Identified risk factors for RTMIs include demographic variables (young males, elderly), behavioral elements (speeding, driving under the influence, non-use of restraints), environmental conditions (poor road infrastructure, adverse weather), and vehicle-related factors (lack of safety features). Pedestrians, cyclists, and motorcyclists are particularly vulnerable due to minimal protection. Socioeconomic determinants, such as limited access to pre-hospital care and delayed presentation, further exacerbate injury severity in resource-limited settings. Surveillance data also highlight the role of comorbidities and pre-existing musculoskeletal conditions in influencing outcomes.
RTMIs manifest with a spectrum of presentations, ranging from isolated soft tissue injuries to polytrauma with life-threatening sequelae. Common features include pain, swelling, deformity, impaired function, and neurovascular compromise at the injury site. High-energy trauma often results in open fractures, crush injuries, and compartment syndromes, necessitating urgent intervention. Clinical assessment requires systematic evaluation to identify occult injuries, associated organ trauma, and potential complications such as fat embolism syndrome or deep vein thrombosis. Functional impairment and psychological sequelae are frequent, underscoring the need for comprehensive multidisciplinary care.
Diagnosis of RTMIs relies on a combination of clinical evaluation and imaging modalities. Standardized trauma assessment protocols, such as Advanced Trauma Life Support (ATLS), guide initial stabilization and prioritization of life-threatening conditions. Radiographs remain the mainstay for detecting fractures and dislocations, while computed tomography (CT) and magnetic resonance imaging (MRI) provide superior delineation of complex injuries, soft tissue damage, and occult pathology. Ultrasonography is increasingly utilized for bedside assessment of musculoskeletal and vascular injuries. Laboratory investigations may aid in identifying systemic complications, including rhabdomyolysis and infection.
Management strategies for RTMIs are dictated by injury type, severity, and patient comorbidities. Initial priorities include resuscitation, hemorrhage control, and stabilization of fractures. Definitive management encompasses surgical interventions (open reduction, internal fixation, external fixation), soft tissue repair, and rehabilitation. Early mobilization, pain control, and prevention of secondary complications are integral to optimizing outcomes. Multidisciplinary collaboration involving trauma surgeons, orthopedic specialists, physiotherapists, and mental health professionals is critical for holistic care. In resource-constrained settings, adaptation of guidelines to local realities is necessary to maximize benefit.
Recent years have witnessed significant advancements in the management of RTMIs. Minimally invasive surgical techniques, such as intramedullary nailing and percutaneous fixation, have reduced morbidity and accelerated recovery. Biologic therapies, including bone morphogenetic proteins and stem cell applications, are under investigation for enhancing fracture healing. Telemedicine and electronic health records are facilitating remote monitoring and surveillance, particularly in rural areas. Population-level interventions, such as trauma registries and real-time injury surveillance systems, are improving data quality and supporting evidence-based policy-making. Artificial intelligence and machine learning are being explored for predictive modeling and personalized risk stratification.
International and national guidelines, including those from the WHO, American Academy of Orthopaedic Surgeons (AAOS), and National Institute for Health and Care Excellence (NICE), emphasize the importance of prevention, prompt diagnosis, and multidisciplinary management of RTMIs. Key recommendations include implementation of road safety measures (seat belts, helmets, speed limits), establishment of trauma systems, standardized injury reporting, and integration of rehabilitation services. Population surveillance is advocated as a cornerstone for monitoring trends, evaluating interventions, and guiding resource allocation. Continuous education and training of healthcare personnel are essential to maintain quality care standards.
Population surveillance of road traffic musculoskeletal injuries is imperative for understanding and mitigating the global burden of trauma. Integration of robust surveillance systems, evidence-based clinical practices, and targeted preventive strategies can substantially reduce morbidity, improve functional outcomes, and inform health policy. Continued research, technological innovation, and capacity-building are necessary to address evolving challenges and enhance the care of individuals affected by RTMIs across diverse healthcare settings.
1.
According to JAMA, 5 alpha-reductase inhibitors are not significantly linked to prostate cancer mortality.
2.
As EGFR internalization is decreased, BUB1 controls EGFR signaling.
3.
New therapeutic strategies raised to prevent and resist metastasis in lymph nodes of breast cancer
4.
An understudied type of breast cancer poses a lurking threat
5.
More men with prostate cancer are avoiding unnecessary surgery
1.
Evidence-Based Approaches in Hematology for Modern Medicine
2.
The Importance of Having a Quick and Effective Heparin Antidote
3.
Cardio-Oncology: Managing Heart Failure in Survivors of Cancer
4.
A Visual Journey Through Penile Cancer: Examining the Impact of Photos
5.
Targeted Therapies for Breast Cancer: What’s New?
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
1.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD
4.
Importance of Cancer Screening and Early Detection
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation